Filing Details
Avantor, Inc. (NYSE:AVTR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 29, 2026.
The Healthcare company reported Q0 revenue of .
Filing Details Avantor, Inc. (NYSE:AVTR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 29, 2026. The Healthcare company reported Q0…

Avantor, Inc. (NYSE:AVTR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 29, 2026.
The Healthcare company reported Q0 revenue of .
Avantor, Inc.'s stock currently trades at $14.38 with a market capitalization of $7.8B.
The 10-Q provides Avantor, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Avantor, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View AVTR Stock Page
Browse all filings on our AVTR SEC filings page.
Public companies like Avantor, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
NYSE · AVTR
$14.42
Up: +$0.16 · +1.12%
Live quote updated
Keep reading